OPTIMAX HOLDINGS BERHAD

KLSE (MYR): OPTIMAX (0222)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

0.69

Today's Change

+0.005 (0.73%)

Day's Change

0.675 - 0.69

Trading Volume

120,800

Overview

Market Cap

373 Million

NOSH

540 Million

Avg Volume (4 weeks)

312,484

4 Weeks Range

0.675 - 0.70

4 Weeks Price Volatility (%)

60.00%

52 Weeks Range

0.65 - 0.845

52 Weeks Price Volatility (%)

20.51%

Previous Close

0.685

Open

0.68

Bid

0.675 x 49,400

Ask

0.69 x 68,300

Day's Range

0.675 - 0.69

Trading Volume

120,800

Financial Highlight

Latest Quarter | Ann. Date

30-Jun-2023 [#2] | 24-Aug-2023

Next QR | Est. Ann. Date

30-Sep-2023 | 29-Nov-2023

T4Q P/E | EY

25.89 | 3.86%

T4Q DY | Payout %

3.48% | 90.05%

T4Q NAPS | P/NAPS

0.11 | 6.27

T4Q NP Margin | ROE

14.28% | 24.23%

Market Buzz
Company Profile

Sector: HEALTH CARE

Sector: HEALTH CARE

Subsector: HEALTH CARE PROVIDERS

Subsector: HEALTH CARE PROVIDERS

Description:

Optimax Holdings Sdn Bhd is a Malaysia-based company, which provides eye specialist services. The Company offers a range of services in medical ophthalmology at its specialist centers. The Company provides treatments relating to eye and vision difficulties or impairment covering refractive error, cataract, glaucoma, macular degeneration, diabetic retinopathy and other eye diseases and disorders. The eye specialist services, which are performed by eye surgeons include: refractive surgery comprising laser vision correction and implant vision correction; treatment of eye diseases and disorders including cataract surgery and other eye medical treatment; consultation and dispensary services comprising doctor consultation and medication; and oculoplastic surgery. The Company operates approximately 13 eye specialist centers across Malaysia.

Discussions
3 people like this. Showing 50 of 414 comments

bojed

go go go!

2022-10-14 16:16

bojed

Relax.

2022-10-21 14:24

bojed

NO MORE RELAXING! GO GO GO!!!

2022-10-26 10:16

chiahs

27Oct2022, Bursa Securities has approved the Transfer FROM THE ACE MARKET TO THE MAIN MARKE
https://www.klsescreener.com/v2/announcements/view/3628057

2022-10-27 13:55

chiahs

27Oct2022, Bursa Securities has approved the Transfer FROM THE ACE MARKET TO THE MAIN MARKE
https://www.klsescreener.com/v2/announcements/view/3628057

2022-10-27 13:55

bojed

INI KALILAH!

2022-10-27 16:54

bojed

TOMORROW!

2022-11-02 13:05

wallstreetrookie

Optimax is one of the most successful IPO on the healthcare ACE market. More successful for Cengild

2022-11-02 16:50

wallstreetrookie

I have been holding since IPO

2022-11-02 16:50

wallstreetrookie

Optimax is the next Greatech. You just watch

2022-11-02 16:50

Godafall

Let's see what will happen tmr

2022-11-02 16:56

wallstreetrookie

Really love the management team of Optimax. This company gives me the vibes like Harnlen. The growth potential of Optimax is endless. A lot of investors are putting money in healthcare; Eye-specialist services will keep expanding at an estimated CAGR of 6% as Malaysia aging population grows and increased demand for cataract treatments.

I am super bullish

2022-11-02 18:01

wallstreetrookie

Trust me, take some money and put it into Optimax-WA and hold until 2026. You might be able to retire early

2022-11-02 18:05

bojed

KALI INILAH!

2022-11-04 18:06

Akifuyu

need to wait another 1 month

2022-11-07 16:30

Serenevalley

One month also cannot

2022-11-07 20:06

bojed

Dah lama sangat rehat ni... Come on!

2022-11-08 10:05

Serenevalley

No lah

2022-11-08 19:15

Akifuyu

support level at 0.70?

2022-11-10 14:53

wallstreetrookie

Sure, Optimax is a long term play

2022-11-10 15:06

Lightofheaven

Optimax bought
Optimax-wa also bought

Keep for long term and grannie will thanks me.

Drinking my starbuck first

2022-12-05 11:31

JTleong

Optimax is all about the patience. Lets go

2022-12-08 00:36

Lightofheaven

Optimax continue to fly fly fly..
strong company and investor is full of confident

2022-12-13 08:21

Lightofheaven

lai liao..kick lai liao..lai lai lai..
talk east talk west talk kok.

2022-12-15 16:58

Lightofheaven

Optimax is the boss

2022-12-15 16:58

nasgee

afternoon flyyy fasetrrrr

2022-12-21 11:24

Lightofheaven

hold tight2 for sure
Optimax gogogo

2022-12-21 12:21

wallstreetrookieNEW

Sold Optimax. Time to take profits and cash out

2022-12-22 15:43

Lightofheaven

i see lots of potential in this optimax..invest and keep for promising profit return.

2023-01-13 09:41

kimpau

stay tuned!!! more n more fantastic good news ahead!!! golden black horse which the price will be RM1.18 within few months!!!

2023-02-03 10:27

kimpau

the warrant of Optimax will double triple your $$$ !!!!

2023-02-03 10:28

ming

198. Regarding the issue of overcrowding in public health facilities, several measures will be undertaken.

The nation’s health capacity will be optimised by outsourcing patients from overcrowded hospitals to other hospitals, including university hospitals, military hospitals and private hospitals.

2023-02-27 00:27

Peace99

Why suddenly down so much?

2023-02-28 15:55

Peace99

Young ppl go for Lasik, seniors go for cataract--replacement of lens by artificial lens. Johor clinic will attract Singaporeans, when they come over for happy weekends! So, why down so much? I top up some already.

2023-02-28 16:27

kimpau

Optimax Holdings - FY22: Earnings and DPS In-line
Date:
2023-03-01
Firm:
MAYBANK
Stock:
OPTIMAX
Price Target:
0.86
Price Call:
BUY
Last Price:
0.745
Upside/Downside:
+0.115 (15.44%)
Maintain BUY With Higher TP of MYR0.86
Optimax’s FY22 core net profit was within our expectations, coming in at MYR14.7m, making up 100%/97% of our/consensus FY22E earnings forecast. We adjust FY23E/FY24E by +2%/-11%, factoring for minor housekeeping and leaving room for potential delays in the construction of the Kempas hospital, which we now assume to commence operations by FY25 (prev. 2HFY24). We also introduce FY25E forecasts. Maintain BUY with a higher, DCF-based TP of MYR0.86 (prev. MYR0.84).

4Q22: Slight Margin Contraction as New Centres Open
4Q22 core net profit increased to MYR3.8m (+7% YoY, 4% QoQ) aided by maiden revenue contribution from newly opened eye specialist centres, bringing 4Q22 revenue to MYR28.4m (+6.8% YoY, -1.1% QoQ). We believe the new loss-making centres which opened in 2H22 were the cause of the EBITDA and PBT margin contractions, both YoY and QoQ. However, net profit margins remained level (+0.1 ppt YoY) or increased (+0.7ppts QoQ) as minority shareholder resident doctors shared in the losses of the new centres.

Steady FY22 Core Operations; DPS Expectations Met
We remain upbeat on Optimax’s core operations, with FY22 core net profit growing by 20% YoY to MYR14.7m, contributed by higher revenue of MYR108m (+22% YoY) which was driven by the re-opening of the economy, resilient demand for eye surgeries, and maiden revenue contribution from new centres. As expected, Optimax announced a second interim DPS of 1.2 sen, which will be paid out on 30 Mar 2023. This brings total DPS announced for FY22 to 2.4 sen (1.2 sen announced in 3Q22), which translates to total dividends of MYR13.0m and a dividend payout ratio of 88% of core net profit. We maintain our DPR assumptions of 80% for FY23E/FY24E/FY25E.

Expansion Plans Continue
In the 3Q22 results briefing, management shared that the Bahau ACC and Cheras satellite clinic were fully operational by end-3Q22, with 2 new satellite clinics slated to open in 4Q22. Management also shared intentions to open 7 new satellite clinics in FY23. Moving forward, we expect higher revenue contribution from consultations and treatment of other eye diseases, but minor margin contractions as new centres steadily mature.

Source: Maybank Research - 1 Mar 2023

2023-03-01 12:19

kimpau

Summary
Optimax Holdings Bhd’s (OPTIMAX) 4Q22 core net profit improved 7.5% YoY to RM3.8m, bringing a 20.0% YoY increase on its FY22 core net profit to RM14.7m. The results came in within expectation, amounting to 102.1% of our full year forecast of RM14.4m. Meanwhile, an interim dividend of 1.2 sen per share, payable on 30th March 2023 was declared.
QoQ, core net profit showed an improvement of 4.1% to RM3.8m, despite a drop of 1.1% QoQ decline in its revenue to RM28.4m and this was mainly due to the lower minority interest of –RM0.2m registered for 4Q22 vs RM1.1m in 3Q22.
FY22 core net profit climbed 20.0% YoY, mainly attributed from (i) the increase in revenue arising from higher number of surgeries conducted amid economy reopening, (ii) effective marketing effort from ongoing promotions via online platforms, and (iii) better control over operating costs by leveraging on the experience gained from multiple lockdowns since March 2020.
Moving forward, OPTIMAX will continue to boost the capacity of its Ambulatory Care Centre (ACC) in regions other than central Malaysia by hiring more surgeons. Meanwhile, the group continued to seek strategic locations to set up more satellite clinics to support its growth, targeting 5 satellite clinics in FY23.
We expect its new ACC in Bahau, Negeri Sembilan and satellite clinic in Taman Sutera, Johor which were both established in FY22, would secure more patients and operate above break-even in the following 6-12 months, resulting in a higher margin for the group.
There is no material development pertaining to both MoU entered into with Selgate Healthcare Sdn. Bhd., as well as with Sena Resources Sdn. Bhd. and Kempas Eye Specialist Hospital Sdn. Bhd.
Valuation & Recommendation
Although the reported earnings came in within our expectations, we upgrade our FY23f earnings forecast by 6.9% to RM15.5m, taking into account the higher expectation on number of surgeries to be conducted amid economic reopening. Meanwhile, the core net profit forecast for FY24f is introduced at RM17.6m.
We maintained our BUY recommendation on OPTIMAX with a revised target price of RM1.15 (from RM1.07). The target price is based on the assigned target PER of 40.0x to our revised FY23f EPS of 2.9 sen.
Risks to our recommendation include the possible resurgence of Covid-19 infections which may result in postponement of surgeries. Besides, the inflationary pressure amid rising food and energy prices remains as threat to local economy.
Source: Mplus Research - 1 Mar 2023

2023-03-01 12:20

kimpau

We maintained our BUY recommendation on OPTIMAX with a revised target price of RM1.15 (from RM1.07). The target price is based on the assigned target PER of 40.0x to our revised FY23f EPS of 2.9 sen.

2023-03-01 12:21

kimpau

the warrant of Optimax will double triple your $$$ !!!!

2023-03-01 12:21

jackjason

Wah! PE 40.0X. If the grow not as expected will GG...............

2023-03-05 23:32

speakup

why buy an overvalued counter, when u can buy so many other undervalued gems?

2023-03-06 07:47

Edmundtrade

Guess Healthcare stock will be defensive choice when the market bad especially now.....hopefully Optimax is one of them :)

2023-03-16 16:18

Peace99

I like and holding optimax.....only worry that ppl, especially the seniors, under the bad economy now, will opt for gov eye clinics as they are almost free!

2023-03-31 09:45

Lightofheaven

Something big is brewing...
More business means more profit this company took

2 months ago

Lightofheaven

lets go optimax..
diversify the business and Go Strong.

1 month ago

Sarwajagat00

Looks like Optimax tak bergerak byk selepas made that announcement 😅

1 month ago

Peace99

Make sense to combine the eye and aesthetic! Topped up some.

1 month ago

Lightofheaven

yaya..top up before if fly

1 month ago

fortunefire

overpriced....

3 weeks ago

speakup

Should be ⅓ of current price

3 weeks ago

Post a Comment